Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
The Lancet Global Health Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study 04:06 - 18 Oct 2018